47. Reisner Y; Kapoor N, O'Reilly RJ, Good RA: Allogeneic bone marrow trans- 
plantation using stem cells fractionated by lectins: III. In vitro 
analysis of human and monkey bone marrow cells fractionated by sheep red 
blood cells and soybean agqlutini. Lancet 1980; 11:1320-1323. 
48. Newberger PE, Latt SA, Pesando JM, Gustashaw K, Powers M, Chaganti RKS, 
O'Reilly RJ: Leukemic relapse in donor cells after allogeneic bone marrow 
transplantation. N Engl J Med 1981; 304:712-714. 
49. O'Reilly RJ, Reisner Y, Kapoor N: The use of separated allogeneic hemato- 
poietic precursors to circumvent graft vs host disease following marrow 
transplantation. In: Burchenal JH, Oettgen HF, eds. Cancer - Achievements. 
Challenges, and Prospects for the 1 980 ' s . Proc 1980 Inti Symp on Cancer, 
Vol. 2, New York: Grune and Stratton, Inc., 1981:649-662. 
50. Pollack MS, Kapoor N, Sorell M, Morishima Y, Silver DM, Dupont B, O'Reilly 
RJ: Absence of demonstrable suppressor cell activity in a severe combined 
immunodeficiency patient with a sustained engraftment of DR positive 
maternal T cells. Transplant Proc 1981; 13:270-272. 
51. O'Reilly RJ, Lee FK, Grossbard E, Kapoor N, Kirkpatrick D, Dinsmore R, 
Stutzer C, Shah KV, Nahmias AJ: Papovavirus excretion following marrow 
transplantation: Incidence and association with hepatic dysfunction. 
Transplant Proc 1981; 13:262-266. 
52. Kapoor N, Kirkpatrick D, Blaese RM, Oleske J, Hilgartner MH, Chaganti RKS, 
Good RA, O'Reilly RJ: Reconstitution of normal megakaryocytopoieis and 
immunologic functions in Wiskott-Aldrich syndrome by marrow transplanta- 
tion following myeloabl ation and immunosuppression with busulfan and 
cyclophosphamide. Blood 1981; 57:692-696. 
53. Sorell M, Kapoor N, Kirkpatrick D, Rosen JF, Chaganti RSK, Lopez C, Dupont 
3, Pollack MS, Terrin BN, Harris MB, Vine D,Rose JS, Goossen C, Lane J, 
Good RA, O'Reilly RJ: Marrow transplantation for juvenile osteopetrosis. 
A- J Med 1981; 70:1280-1287. 
5-. : - ; sner Y, Kapoor N, Kirkpatrick D, Pollack MS, Dupont B, Chaganti RSK, 
3:od RA, O'Reilly RJ: Transplantation for acute leukemia with HLA-A & B 
' rnidentical parental marrow cells fractionated with soybean agglutinin 
i z sheep red blood cells. Lancet 1981; 2:327-331. 
53. l-:od RA, Day NK, Cunningham-Rundles C, O'Reilly RJ, Auerbach AD, Fernandes 
3: Genetics of the primary immunodeficiency diseases. In: Meischer PA, et 
cl, eds. Manarini Series on Iinriunopathology . Volume 3. Basel, 
Switzerland: Schwabe & Co., 1981:184-240. 
56. Incefy G, O'Reilly RJ, Kapoor N, Iwata T, Goldstein G, Good RA: In vitro 
differentiation of human marrow T cell precursors by thymic factors in 
severe combined immunodeficiency. Transplantation 1981; 32 : 299-305 . 
57. Iwata T, Incefy G, Cunningham-Rundles S, Cunningham-Rundles C, Smithwick 
EM, Geller N, O'Reilly RJ, Good RA: Circulating thymic hormone activity 
in patients with primary and secondary immunodeficiency disease. Am J Med 
1981; 71:385-394. 
Recombinant DNA Research, Volume 12 
[ 483 ] 
